Zhejiang Haisen Pharmaceutical Co Ltd

Zhejiang Haisen maintains a strong liquidity position, with a current ratio of 11.01, indicating that it holds significantly more current assets than current liabilities. However, the company reported negative free cash flow of -10.56 million CNY, driven by capital expenditures of -152.26 million CNY, which suggests a heavy investment in long-term assets. The company’s liquidity risk is assessed as medium, primarily due to its negative net cash position after subtracting total debt. In terms of profitability, Zhejiang Haisen reported a net income of 135.88 million CNY, with a return on equity (ROE) of 9.1% and a return on assets (ROA) of 8.33%. These figures are strong relative to the industry median, indicating efficient use of equity and assets to generate profit. The company’s gross profit margin of 45.4% (241.94 million CNY on 532.26 million CNY revenue) is also robust, suggesting effective cost control in production. The company’s revenue is concentrated in a single business segment, with no disclosed geographic diversification beyond China. This lack of diversification increases exposure to domestic regulatory and economic risks. The company’s operating income of 156.45 million CNY reflects strong operational performance, but the absence of segment-level data limits the ability to assess growth drivers. Looking ahead, the company’s capital expenditures suggest a focus on long-term growth, but the negative free cash flow indicates that this growth is currently being funded through asset sales or financing. The outlook for the current fiscal year is positive, with revenue expected to grow, though the pace of growth is not disclosed. The company’s dilution risk is assessed as low, with no significant dilution sources identified in the latest filings. Recent filings and transcripts do not indicate any material events that would significantly alter the company’s financial trajectory. The company’s debt-to-equity ratio of 0.01 is very low, suggesting a conservative capital structure with minimal reliance on debt financing. However, the negative free cash flow and high capital expenditures may signal a shift in strategy or expansion plans. The company’s risk profile is generally favorable, with low debt and strong profitability. However, the lack of geographic and segment diversification, combined with the negative free cash flow, introduces some uncertainty regarding long-term sustainability.